SMAD3 and myocardial infarction: Taken together, these data demonstrate that inactivation of ROS-induced Smad3 signaling and miR-29b upregulation mediate the anti-fibrotic effect of carvedilol in MI-induced cardiac fibrosis (Figure 6).